Sorin launches Ovatio ICDs (implantable cardioverter defibrillators) in Japan:
This article was originally published in Clinica
Sorin Group has launched its Ovatio DR implantable cardioverter defibrillators (ICDs) in Japan. The Milan, Italy company claims that the Ovatio product line comprises the world's smallest such devices, and hence that their thinness suits for Japanese body size. The single and dual chamber models, Ovatio VR 6250 and DR 6550 ICD, have received regulatory and reimbursement approval from the Japanese health ministry (MHLW). Both models are immediately available. The dual chamber Ovatio DR includes a feature designed to reduce unnecessary stimulation in the right ventricle, thus decreasing the risk of heart failure and atrial fibrillation, as well as a component intended to protect patients from inappropriate shocks.
You may also be interested in...
The first trial of the new Flash ultra-high dose radiation therapy with Varian Medical Systems’ ProBeam particle accelerator has begun. Agum Sharda, Varian’s senior director of Flash, says the technology could be a major advance for cancer patients.
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.